Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-025355
Filing Date
2018-09-26
Accepted
2018-09-26 20:54:14
Documents
2
Period of Report
2018-09-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2387
2 EX-24 DOCUMENT attachment1.htm EX-24 4609
  Complete submission text file 0000899243-18-025355.txt   8433
Mailing Address 395 WINCHESTER COMPANY, LLC 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER COMPANY, LLC 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS HOLDING COMPANY, LLC (Issuer) CIK: 0001655759 (see all company filings)

EIN.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AUDENTES THERAPEUTICS, INC. 101 MONTGOMERY ST., SUITE 2650 SAN FRANCISCO CA 94104
Business Address
PARMAR KUSH (Reporting) CIK: 0001664281 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38672 | Film No.: 181089270